163 related articles for article (PubMed ID: 3034414)
1. Analysis of c-myc expression in a human hepatoma cell line.
Huber BE; Thorgeirsson SS
Cancer Res; 1987 Jul; 47(13):3414-20. PubMed ID: 3034414
[TBL] [Abstract][Full Text] [Related]
2. Characterization of a transforming N-ras gene in the human hepatoma cell line Hep G2: additional evidence for the importance of c-myc and ras cooperation in hepatocarcinogenesis.
Richards CA; Short SA; Thorgeirsson SS; Huber BE
Cancer Res; 1990 Mar; 50(5):1521-7. PubMed ID: 2154325
[TBL] [Abstract][Full Text] [Related]
3. Amplification, rearrangements, and enhanced expression of c-myc in chemically induced rat liver tumors in vivo and in vitro.
Suchy BK; Sarafoff M; Kerler R; Rabes HM
Cancer Res; 1989 Dec; 49(23):6781-7. PubMed ID: 2684400
[TBL] [Abstract][Full Text] [Related]
4. Expression of the L-myc gene is under positive control by short-lived proteins.
Saksela K
Oncogene; 1987; 1(3):291-6. PubMed ID: 2838780
[TBL] [Abstract][Full Text] [Related]
5. Absence of a paused transcription complex from the c-myc P2 promoter of the translocation chromosome in Burkitt's lymphoma cells: implication for the c-myc P1/P2 promoter shift.
Strobl LJ; Kohlhuber F; Mautner J; Polack A; Eick D
Oncogene; 1993 Jun; 8(6):1437-47. PubMed ID: 8502472
[TBL] [Abstract][Full Text] [Related]
6. The human breast carcinoma cell line SW 613-S: an experimental system to study tumor heterogeneity in relation to c-myc amplification, growth factor production and other markers (review).
Lavialle C; Modjtahedi N; Lamonerie T; Frebourg T; Landin RM; Fossar N; Lhomond G; Cassingena R; Brison O
Anticancer Res; 1989; 9(5):1265-79. PubMed ID: 2686529
[TBL] [Abstract][Full Text] [Related]
7. The block of elongation in c-myc exon 1 is abolished in Burkitt's lymphoma cell lines with variant translocation.
Eick D; Polack A; Kofler E; Bornkamm GW
Oncogene; 1988 Oct; 3(4):397-403. PubMed ID: 3078949
[TBL] [Abstract][Full Text] [Related]
8. The mechanism of inactivation of the normal c-myc gene locus in human Burkitt lymphoma cells.
Nishikura K; Murray JM
Oncogene; 1988 May; 2(5):493-8. PubMed ID: 3131718
[TBL] [Abstract][Full Text] [Related]
9. Tissue-specific post-transcriptional regulation of c-myc expression in normal and H-2K/human c-myc transgenic mice.
Morello D; Asselin C; Lavenu A; Marcu KB; Babinet C
Oncogene; 1989 Aug; 4(8):955-61. PubMed ID: 2668846
[TBL] [Abstract][Full Text] [Related]
10. Coexistence of a c-myc mRNA initiated in intron 1 with the normal c-myc mRNA and similar regulation of both transcripts in mammalian cells.
Ray D; Robert-Lézénès J
Oncogene Res; 1989; 5(1):73-8. PubMed ID: 2674860
[TBL] [Abstract][Full Text] [Related]
11. Characterization of the human C6 promoter: requirement of the CCAAT enhancer binding protein binding site for C6 gene promoter activity.
González S; López-Larrea C
J Immunol; 1996 Sep; 157(6):2282-90. PubMed ID: 8805625
[TBL] [Abstract][Full Text] [Related]
12. Expression of cellular oncogenes: unrearranged c-myc gene but altered promoter usage in radiation-induced thymoma.
Bandyopadhyay SK; D'Andrea E; Fleissner E
Oncogene Res; 1989; 4(4):311-8. PubMed ID: 2475843
[TBL] [Abstract][Full Text] [Related]
13. Expression of P0- and P3-RNA from the normal and translocated c-myc allele in Burkitt's lymphoma cells.
Eick D; Polack A; Kofler E; Lenoir GM; Rickinson AB; Bornkamm GW
Oncogene; 1990 Sep; 5(9):1397-402. PubMed ID: 2216463
[TBL] [Abstract][Full Text] [Related]
14. Tumorigenicity and transcriptional modulation of c-myc and N-ras oncogenes in a human hepatoma cell line.
Huber BE; Dearfield KL; Williams JR; Heilman CA; Thorgeirsson SS
Cancer Res; 1985 Sep; 45(9):4322-9. PubMed ID: 2992777
[TBL] [Abstract][Full Text] [Related]
15. Exogenous c-myc gene overexpression interferes with early events in F9 cell differentiation.
Onclercq R; Babinet C; Cremisi C
Oncogene Res; 1989; 4(4):293-302. PubMed ID: 2671866
[TBL] [Abstract][Full Text] [Related]
16. Negative regulation of c-myc transcription involves myc family proteins.
Cleveland JL; Huleihel M; Bressler P; Siebenlist U; Akiyama L; Eisenman RN; Rapp UR
Oncogene Res; 1988; 3(4):357-75. PubMed ID: 2976141
[TBL] [Abstract][Full Text] [Related]
17. Modulation of c-myc, c-myb, c-fos, c-sis and c-fms proto-oncogene expression and of CSF-1 transcripts and protein by phorbol diester in human malignant histiocytosis DEL cell line with 5q 35 break point.
Gogusev J; Barbey S; Nezelof C
Anticancer Res; 1993; 13(4):1043-7. PubMed ID: 8352523
[TBL] [Abstract][Full Text] [Related]
18. Modulation of nuclear proto-oncogene expression and cellular growth in myeloid leukemic cells by human interferon alpha.
Marshall AH; Alper D; Hiscott J
J Cell Physiol; 1988 May; 135(2):324-31. PubMed ID: 3163696
[TBL] [Abstract][Full Text] [Related]
19. Mouse fibroblasts transformed with the human c-myc gene express a high level of mRNA but a low level of c-myc protein and are non-tumorigenic in nude mice.
Ray R; Thomas S; Miller DM
Oncogene; 1989 May; 4(5):593-600. PubMed ID: 2657574
[TBL] [Abstract][Full Text] [Related]
20. Transcription of the c-myc oncogene is altered in spontaneously immortalized rodent fibroblasts.
Tavassoli M; Shall S
Oncogene; 1988 Apr; 2(4):337-45. PubMed ID: 3283652
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
